Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans

Kristen D Kelley, Harvey Checkoway, Deborah A Hall, Stephen G Reich, Chris Cunningham, Irene Litvan, Kristen D Kelley, Harvey Checkoway, Deborah A Hall, Stephen G Reich, Chris Cunningham, Irene Litvan

Abstract

Background: Progressive supranuclear palsy (PSP) is a tauopathy that has a multifactorial etiology. Numerous studies that have investigated lead exposure and traumatic brain injury (TBI) as risk factors for other tauopathies, such as Alzheimer's disease, but not for PSP. Objective: We sought to investigate the role of firearm usage, as a possible indicator of lead exposure, and TBI as risk factors for PSP in a population of military veterans. Methods: We included participants from a larger case-control study who reported previous military service. Our sample included 67 PSP cases and 68 controls. Participants were administered a questionnaire to characterize firearm use in the military and occurrence of TBI. Results: Cases were significantly less educated than controls. In unadjusted analyses, the proportion of PSP cases (80.6%) and controls (64.7%) who reported use of firearms as part of their military job was positively associated with PSP, odds ratio (OR) 2.2 (95% CI: 1-5.0). There were no significant case-control differences in mean service duration. There was only a weak association with history of TBI, OR 1.6 (95% CI: 0.8-3.4). In multivariate models, firearm usage (OR 3.7, 95% CI: 1.5, 9.8) remained significantly associated with PSP. Conclusions: Our findings show a positive association between firearm usage and PSP and an inverse association between education and PSP. The former suggests a possible etiologic role of lead. Further studies are needed to confirm the potential etiologic effects of metals on PSP. The study was registered in clinicaltrials.gov. ClinicalTrials.gov Identifier: NCT00431301.

Keywords: PSP; case-control study; firearms; military; traumatic brain injury.

References

    1. Ludolph AC, Kassubek J, Landwehrmeyer BG, Madelkov E, Madelkov E-M, Burn DJ, et al. . Tauopathies with Parkinsonism: clinical spectrum, neuropatholic basis, biological markers, and treatment options. Eur J Neurosci. (2009) 16:297–309. 10.1111/j.1468-1331.2008.02513.x
    1. Swerdlow R, Golbe L, Parks J, Cassarino D, Binder D, Grawey A, et al. . Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem. (2000) 75:1681–4. 10.1046/j.1471-4159.2000.0751681.x
    1. Litvan I. Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord. (2003) 18(Suppl. 6):S43–50. 10.1002/mds.10562
    1. Houghton D, Litvan I. Unraveling progressive supranuclear palsy: from the bedside back to the bench. Parkinson Relat Disord. (2007) 13:S341–6. 10.1016/S1353-8020(08)70028-2
    1. Litvan I, Lees PSJ, Cunningham CR, Rai SN, Cambon AC, Standaert DG, et al. . Environmental and occupational risk factors for progressive supranuclear palsy: case-control study. Mov Disord. (2016) 3:644–52. 10.1002/mds.26512
    1. Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, et al. . Alzheimer's disease (AD) like pathology in aged monkeys following infantile exposure to environmental metal lead (Pb): Evidence for developmental origin and environmental link for AD. J Neurosci. (2008) 28:7. 10.1523/JNEUROSCI.4405-07.2008
    1. Bihaqi SW, Zawia NH. Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb). Neurotoxicology (2013) 39:95–101. 10.1016/j.neuro.2013.07.010
    1. Bihaqi SW, Bahmani A, Adem A, Zawia NH. Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of middle aged mice: relevance to AD. Neurotoxicology (2014) 44:114–20. 10.1016/j.neuro.2014.06.008
    1. Daneshvar DH, Goldstein LE, Kiernan PT, Stein TD, McKee AC. Post-traumatic neurodegeneration and chronic traumatic encephalopathy. Mol Cell Neurosci. (2015) 66:81–90. 10.1016/j.mcn.2015.03.007
    1. Gardner RC, Yaffe K. Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci. (2015) 66:75–80. 10.1016/j.mcn.2015.03.001
    1. Novotny T, Cook M, Hughes J, Lee SA. Lead exposure in a firing range. Am J Public Health (1987) 77:1225–6. 10.2105/AJPH.77.9.1225
    1. Beaucham C, Page E, Alarcon WA, Calvert GM, Methner M, Schoonover TM. Indoor firing ranges and elevated blood lead levels - United States, 2002-2013. Cen Dis Control Prevent. (2014) 63:347–51.
    1. Fisher-Fischbein J, Fischbein A, Melnick HD, Barden W. Correlation between biochemical indicators of lead exposure and semen quality in a lead-poisoned firearms instructor. JAMA (1987) 257:803–5. 10.1001/jama.1987.03390060093031
    1. Goldberg RL, Hicks AM, O'Leary LM, London S. Lead exposure at uncovered outdoor firing ranges. J Occup Med. (1991) 33:718–9. 10.1097/00043764-199106000-00013
    1. Svensson B, Schütz A, Nilsson A, Skerfving S. Lead exposure in indoor firing ranges. Int Arch Occup Environ Health (1992) 64:219–21. 10.1007/BF00378278
    1. Payton M, Riggs KM, Spiro A III, Weiss ST, Hu H. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol. (1998) 20:19–27. 10.1016/S0892-0362(97)00075-5
    1. Weisskopf MG, Wright RO, Schwartz J, Spiro A III, Sparrow D, Aro A, et al. . Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol. (2004) 160:1184–93. 10.1093/aje/kwh333
    1. Niklowitz WJ, Mandybur TI. Neurofibrillary changes following lead encephalopathy. J Neuropathol Exp Neurol. (1975) 34:445–55. 10.1097/00005072-197509000-00006
    1. Dash M, Eid A, Subaiea G, Chang J, Deeb R, Masoud A, et al. . Developmental exposure to lead (Pb) alters the expression of the human tau gene and its products in a transgenic animal model. Neurotoxicology (2016) 55:154–9. 10.1016/j.neuro.2016.06.001
    1. Wright K, Bihaqi SW, Lahouel A, Masoud A, Mushtaq F, Leso A, et al. . Importance of tau in cognitive decline as revealed by developmental exposure to lead. Toxicol Lett. (2018) 284:63–9. 10.1016/j.toxlet.2017.11.041
    1. O'Meara ES, Kukull WA, Sheppard L, Bowen JD, McCormick WC, Teri L, et al. . Head injury and risk of Alzheimer's disease by apolipoprotein E genotype. Am J Epidemiol. (1997) 146:373–84. 10.1093/oxfordjournals.aje.a009290
    1. Schofield PW, Tang M, Marder K, Bell K, Dooneief G, Chun M, et al. . Alzheimer's disease after remote head injury: an incidence study. J Neurol Neurosurg Psychiatry (1997) 62:119–24. 10.1136/jnnp.62.2.119
    1. Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick D, et al. . Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology (2000) 55:1158–66. 10.1212/WNL.55.8.1158
    1. Weiner MW, Friedl KE, Pacifico A, Chapman JC, Jaffee MS, Little DM, et al. . Military risk factors for Alzheimer's disease. Alzheimers Dement. (2013) 9:445–51. 10.1016/j.jalz.2013.03.005
    1. Abner EL, Nelson PT, Schmitt FA, Browning SR, Fardo DW, Wan L, et al. . Self-reported head injury and risk of late-life impairement and AD pathology in an AD Center cohort. Dement Geriatr Cogn Disord. (2014) 37:294–306. 10.1159/000355478
    1. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. . Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome): Report of the NINDS-SPSP International Workshop. Neurology (1996) 47:1–9. 10.1212/WNL.47.1.1
    1. Folstein MF, Folstein SE, and McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the Clinician. J Psychiatr Res. (1975) 12:189–98. 10.1016/0022-3956(75)90026-6
    1. Duff K, Tometich D, Dennett K. The modified telephone interview for cognitive status is more predictive of memory abilities than the mini-mental state examination. J Geriatr Psychiatry Neurol. (2015) 28:193–7. 10.1177/0891988715573532
    1. Rocca WA, Maragonore DM, McDonnell SK, Schaid DJ. Validation of a telephone questionnaire for Parkinson's disease. J Clin Epidemiol. (1998) 51:517–23. 10.1016/S0895-4356(98)00017-1
    1. Stewart P, Steward W, Heineman E, Dosemeci M, Linet M, Inskip P. A novel approach to data collection in a case-control study of cancer and occupational exposures. Int J Epidemiol. (1998) 25:744–52. 10.1093/ije/25.4.744
    1. R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; (2015).
    1. Golbe LI, Rubin RS, Cody RP, Belsh JM, Duvoisin RC, Grosmann C, et al. . Follow-up study of risk factors in progressive supranuclear palsy. Neurology (1996) 47:148–54. 10.1212/WNL.47.1.148
    1. Vidal JS, Vidailhet M, Derkinderen P, de Gaillarbois TD, Tzourio C, Alperovitch A. Risk factors for progressive supranuclear palsy: a case-control study in France. J Neurol Neurosurg Psychiatry (2009) 80:1271–4. 10.1136/jnnp.2008.149849
    1. Caparros-Lefebvre D, Golbe LI, Deramecourt V, Maurage CA, Huin V, Buee-Scherrer V, et al. . A geographical cluster of progressive supranuclear palsy in northern France. Neurology (2015) 85:1293–300. 10.1212/WNL.0000000000001997

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe